# Endocrinology Referral

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Johnny Cash (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML004-SYN-TD
- Date: 2003-02-27
- Fictional facility: St. Posthumous Health Center
- Fictional author: Gideon Hale, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- To: Ayesha Rahimi, MD, Endocrinology
- Urgency: Routine, within four weeks; to coincide with his diabetes check

## Referral question

Type 2 diabetes above goal in a 71-year-old man with autonomic and peripheral neuropathy and orthostatic hypotension. Please confirm whether diabetic autonomic neuropathy explains his lightheadedness on standing, advise on treating it, and help choose add-on glucose-lowering therapy. **S**

## Questions for the consultant

1. Is diabetic autonomic neuropathy a sufficient explanation for his orthostatic hypotension, and should the earlier Shy-Drager label be carried forward?
2. If the non-drug measures are not enough, which medicine do you recommend, and how should we watch for high pressure lying down?
3. Which add-on glucose-lowering agent is safest, given his risk of unrecognized low glucose, his falls, and his orthostatic hypotension?
4. Do you agree with an HbA1c goal below 7.5 percent?
5. Should his seated blood pressure above 130/80 be treated?

## Pertinent history

Lightheaded on standing, with two falls in six months; he walks with a cane. Seated blood pressure 146/80 mmHg, falling to 112/68 after three minutes standing, while heart rate rises only from 78 to 82. Numb feet with monofilament and vibration sensation reduced to the ankles. He was once told he had Shy-Drager syndrome and wants to know what he really has. HbA1c 8.6 percent on metformin 500 mg twice daily; eGFR 74, urine albumin-creatinine ratio 18 mg/g, vitamin B12 286 pg/mL, TSH and hemoglobin normal. Severe primary open-angle glaucoma with low vision, followed by the eye clinic; dorzolamide added to latanoprost today. No tobacco or alcohol use. Today metformin was raised to 1000 mg twice daily and atorvastatin 40 mg was started, and he began staged standing, head-of-bed elevation, waist-high compression, and 2 liters of fluid a day. No blood pressure medicine is used. **S**

- J. R. (Johnny) Cash was born on February 26, 1932, in Kingsland, Cleveland County, Arkansas, to Ray and Carrie Cash. **D**
- Cash's older brother Jack died in a sawmill accident in 1944. **D**
- In 1957 Cash began taking amphetamines to stay awake on a long road trip, the start of an addiction that lasted about a decade; in a 2002 interview he named amphetamines and barbiturates in the 1960s. **D**
- Cash was hospitalized in 1983 with internal bleeding; after recovering he entered the Betty Ford Clinic for treatment. **D**
- In October 1997 Cash was diagnosed with Shy-Drager syndrome, an illness similar to Parkinson's disease; in a 2000 interview he said the diagnosis was a misdiagnosis. **D**
- Cash later learned he had autonomic neuropathy; in November 2002 he described it as a deadening of the nerve endings in his lower extremities that had taken the strength from his legs, so that he could walk, but not very well. **D**
- Cash was repeatedly hospitalized for pneumonia in his last years; he was treated for pneumonia at Baptist Hospital in Nashville in February 2001, and in November 2002 he said he had had pneumonia four times in three years. **D**
- In November 2002 Cash said about 60 percent of his vision was gone, which he attributed to the neuropathy and the diabetes, and he said he hoped the glaucoma could also be reversed. **D**

1 later historical claim is omitted because it describes events after the index age. See the teaching note.

Baseline: HbA1c: 8.6% (high); Sodium: 138 mmol/L; Potassium: 4.4 mmol/L; Creatinine: 1.04 mg/dL; eGFR: 74 mL/min/1.73 m²; Glucose: 186 mg/dL (high); LDL cholesterol: 128 mg/dL (high); Urine albumin-creatinine ratio: 18 mg/g; ALT: 24 U/L; AST: 22 U/L; Vitamin B12: 286 pg/mL; TSH: 1.9 mIU/L; Hemoglobin: 13.8 g/dL; Intraocular pressure, right eye: 22 mmHg (high); Intraocular pressure, left eye: 24 mmHg (high); Mean RNFL thickness by OCT, right eye: 61 um (low); Mean RNFL thickness by OCT, left eye: 57 um (low); Best-corrected visual acuity, right eye (ETDRS letters): 68 (low); Best-corrected visual acuity, left eye (ETDRS letters): 63 (low); PHQ-2: 1; Mini-Cog: 5. All results are synthetic.

BP 146/80 mmHg; pulse 78 bpm; respirations 16/min; temperature 36.7 °C; oxygen saturation 95% on room air; weight 96 kg; BMI 27.2 kg/m². All vital signs are synthetic.

## Current medications

- Metformin 1000 mg oral tablet, one tablet by mouth twice daily with meals **S**
- Atorvastatin 40 mg oral tablet, one tablet by mouth daily **S**
- Latanoprost 0.005% ophthalmic solution, one drop in each eye at bedtime **S**
- Dorzolamide 2% ophthalmic solution, one drop in each eye twice daily **S**

## Plan so far

- Increase metformin to 1000 mg twice daily and set an individualized HbA1c goal below 7.5%; avoid insulin and sulfonylureas while autonomic neuropathy may blunt warning symptoms of hypoglycemia. Guideline: Standards of Care in Diabetes—2025 (2025); CMID: Clinical Monitoring Intelligence Database, diabetes, glaucoma, and hyperlipidemia monographs (2026) **S**
- Treat neurogenic orthostatic hypotension: stand up in stages, raise the head of the bed, use waist-high compression, drink 2 liters of fluid a day, then midodrine with the last dose at least four hours before bed; check supine blood pressure at each visit. Guideline: Standards of Care in Diabetes—2025 (2025) **S**
- Check HbA1c every three months until at goal, a basic metabolic panel, UACR, and lipids each year, lipids 4 to 12 weeks after starting a statin, and vitamin B12 periodically on metformin. Guideline: Standards of Care in Diabetes—2025 (2025); CMID: Clinical Monitoring Intelligence Database, diabetes, glaucoma, and hyperlipidemia monographs (2026) **S**
- Examine the feet at every visit because of sensory loss; daily self-inspection and protective footwear. Guideline: Standards of Care in Diabetes—2025 (2025); CMID: Clinical Monitoring Intelligence Database, diabetes, glaucoma, and hyperlipidemia monographs (2026) **S**
- Coordinate glaucoma care with the eye clinic: add dorzolamide to latanoprost, check pressure at each visit, and repeat OCT and visual fields every six months; avoid timolol and brimonidine because of bradycardia, bronchospasm, and low blood pressure. Guideline: Primary Open-Angle Glaucoma Preferred Practice Pattern (2025); CMID: Clinical Monitoring Intelligence Database, diabetes, glaucoma, and hyperlipidemia monographs (2026) **S**
- Annual dilated eye examination for diabetic retinopathy; low-vision rehabilitation and home lighting review. Guideline: Standards of Care in Diabetes—2025 (2025); Primary Open-Angle Glaucoma Preferred Practice Pattern (2025) **S**
- Start atorvastatin 40 mg; give PCV20 and recombinant zoster vaccines. Guideline: Standards of Care in Diabetes—2025 (2025) **S**
